Sam Willcocks
Impact in
-
- Antibiotic Use and Resistance
- Microbiology top 5%
- Antimicrobial Peptides and Activities
Papers in
- Epidemiology 14
- Mycobacterium research and diagnosis 7
- Burkholderia infections and melioidosis 6
-
- Tuberculosis Research and Epidemiology 9
- Co-authors
- Brendan W. Wren (18 shared papers)Naomi M. Fuller (1 shared paper)Gwenan M. Knight (1 shared paper)Esther van Kleef (1 shared paper)Quentin J. Leclerc (1 shared paper)Rumina Hasan (1 shared paper)R. E. Glover (1 shared paper)Clare Chandler (1 shared paper)
- Journals
- PLoS ONE (3 papers)Frontiers in Immunology (3 papers)Tuberculosis (2 papers)Microbial Genomics (2 papers)Future Microbiology (2 papers)
- Partner nations
- United KingdomThailandGermany
In The Last Decade
Sam Willcocks
31 papers receiving 764 citations
Sam Willcocks's Hit Papers
Peers
Comparison fields: 5 of 90
- Applied Microbiology and Biotechnology 121
- Microbiology 121
- Molecular Medicine 92
- Infectious Diseases 171
- Endocrinology 40
Countries citing papers authored by Sam Willcocks
This map shows the geographic impact of Sam Willcocks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam Willcocks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam Willcocks more than expected).
Fields of papers citing papers by Sam Willcocks
This network shows the impact of papers produced by Sam Willcocks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam Willcocks. The network helps show where Sam Willcocks may publish in the future.
Co-authors
The 25 scholars most cited alongside Sam Willcocks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antimicrobial resistance and COVID-19: Intersections and implications Hit paper breakdown → | 2021 | 248 |
| 2 | 2017 | 90 | |
| 3 | 2016 | 46 | |
| 4 | 2016 | 37 | |
| 5 | 2013 | 37 | |
| 6 | 2017 | 37 | |
| 7 | 2015 | 32 | |
| 8 | 2006 | 25 | |
| 9 | 2016 | 23 | |
| 10 | 2019 | 21 | |
| 11 | 2022 | 17 | |
| 12 | 2008 | 15 | |
| 13 | 2020 | 14 | |
| 14 | 2022 | 13 | |
| 15 | 2018 | 13 | |
| 16 | 2021 | 12 | |
| 17 | 2021 | 11 | |
| 18 | 2014 | 11 | |
| 19 | 2018 | 10 | |
| 20 | 2020 | 8 |
About Sam Willcocks
Sam Willcocks is a scholar working on Epidemiology, Infectious Diseases, Molecular Biology, Immunology and Molecular Medicine, having authored 32 papers that have together received 777 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (9 papers), Mycobacterium research and diagnosis (7 papers), Burkholderia infections and melioidosis (6 papers), Antibiotic Resistance in Bacteria (6 papers), Glycosylation and Glycoproteins Research (4 papers), Antimicrobial Peptides and Activities (4 papers), Immune Response and Inflammation (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (121 citations), Microbiology (121 citations), Molecular Medicine (92 citations), Infectious Diseases (171 citations) and Endocrinology (40 citations). Sam Willcocks has collaborated with scholars based in United Kingdom, Thailand and Germany. Frequent co-authors include Brendan W. Wren, Naomi M. Fuller, Gwenan M. Knight, Esther van Kleef, Quentin J. Leclerc, Rumina Hasan, R. E. Glover, Clare Chandler, Christopher Finn McQuaid and Karin Gallandat. Their work appears in journals such as PLoS ONE, Frontiers in Immunology, Tuberculosis, Microbial Genomics and Future Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.